3 completed, 1 active not recruiting, 1 recruiting. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 1 | 2 | Completed 2 |
Follow Aphaia Pharma US LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities APHD-012, APHD-002, APHP-012 - Obese With Comorbidities, Obese Patients (BMI ≥ 30 kg/m²) | Phase 2 | Recruiting | Aphaia Pharma US LLC | 102 | 2025-09-12 | 2025-09-16 |
| A Study to Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation in Subjects With a Pathological Oral Glucose Tolerance Test APHD-012, APH-012P - PreDiabetes, Glucose Tolerance Impaired | Phase 2 | Completed | Aphaia Pharma US LLC | 31 | 2023-03-31 | 2024-10-16 |
| A Study of Distal Jejunal-release Dextrose in Obese Participants APHD-012, APHD-012P - Obese | Phase 2 | Active not recruiting | Aphaia Pharma US LLC | 150 | 2022-11-01 | 2024-10-16 |
| Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects Glucose 8 g coated beads (47% w/w), Glucose 12 g coated beads (47% w/w), Glucose 16 g coated beads (47% w/w) - Obese | Phase 1 | Completed | Aphaia Pharma US LLC | 20 | 2020-09-16 | 2025-09-18 |
| Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects coated beads glucose (8 g) and caffeine anhydrous, coated beads glucose (8 g), uncoated beads glucose (8 g) and caffeine anhydrous - Metabolic Syndrome, Obesity | Phase 1 | Completed | Aphaia Pharma US LLC | 20 | 2019-10-25 | 2023-02-06 |
Obesity (4) · Endocrine System Diseases (1) · Glucose Intolerance (1) · Hypertension (1) · Metabolic Syndrome (1) · Non-alcoholic Fatty Liver Disease (1) · Prediabetic State (1)
Glucose (1)
Georgia (2) · Romania (2) · Germany (1) · Puerto Rico (1) · Slovakia (1)
Carmen Vizman (1) · Carmen Vizman, Doctor (1)